This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignees: Bamichem Co., Ltd., Incheon National University Research & Business Foundation, Samjin Pharmaceutical Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 12 
1 out of 1 Years Active: 2026
Title: Kug Hwa Lee: Innovator in Pharmaceutical Research
Introduction
Kug Hwa Lee is a notable inventor based in Yongin-si, Gyeonggi-do, South Korea. She has made significant contributions to the field of pharmaceutical research, particularly in the development of novel compounds. Although she currently holds no granted patents, her work continues to influence the industry.
Latest Patent Applications
Kug Hwa Lee's latest patent application is titled "Novel Adamantane Derivatives as Inhibitors of Focal Adhesion Kinase." This application presents innovative adamantane derivatives that serve as inhibitors of focal adhesion kinase, along with their pharmaceutically acceptable salts, stereoisomers, hydrates, or solvates. The application also includes a pharmaceutical composition comprising these derivatives.
Conclusion
Kug Hwa Lee's research and patent applications reflect her dedication to advancing pharmaceutical science. Her innovative work in developing new compounds showcases her potential impact on the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile